COLL — Collegium Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapSuper Stock

Annual balance sheet for Collegium Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	170	174	186	174	311
Net Total Accounts Receivable
Net Total Receivables	73	83.3	106	183	180
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	256	278	316	420	538
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.9	27.4	27.1	26.4	22
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	306	644	692	1,174	1,143
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	202	239	280	434	458
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	219	458	489	979	948
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	87.4	186	203	195	195
Total Liabilities & Shareholders' Equity	306	644	692	1,174	1,143
Total Common Shares Outstanding